https://www.selleckchem.com/pr....oducts/iacs-13909.ht
0% in the elderly group and 78.4% in the younger group achieved sustained virologic response 12 (P = 0.3. In the modified intention-to-treat population, all patients achieved sustained virologic response 12. A total of 27.5% of patients experienced adverse events. The most frequently observed adverse events was pruritus, and was significantly associated with female sex, the presence of hemodialysis and serum albumin at baseline less then 4.0 g/dL. CONCLUSION Glecaprevir/pibrentasvir therapy was effective and well tolerated, even in
Like
Comment
Share
